References

1. Madisch A et al. Aliment Pharmacol Ther 2004;19(3):271–9.

2. von Arnim U et al. Am J Gastroenterol 2007;102(6):1268–75.

3. Gastroenterological Society of Australia and Digestive Health Foundation. Information about irritable bowel syndrome. Available from: http://cart.gesa.org.au/membes/files/Consumer Information/IBS.pdf Accessed 17/10/17

4. Ottillinger B et al. Wien Med Wochenschr 2013;163(3–4):65–72.

5. Kelber O et al. Wien Med Wochenschr 2016;.

6. Liu CY et al. Neurogastroenterol Motil 2004;16(6):759–64.

7. Vinson B and Holtmann G. Onset of action and efficiency of STW 5 in the clinical setting in patients with functional dyspepsia and irritable bowel syndrome. Mo1881 AGA Abstracts:S-682, 2013.

8. Wegener T and Wagner H. Phytomedicine 2006;13(Suppl 5):20–35.

9. IMS, $MAT 05.2017 ( OTC1 Cat. 03 ).